| Not Yet Recruiting | Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) NCT07241585 | Case Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Basal Cell Carcinoma Chemoprevention Trial NCT05212246 | VA Office of Research and Development | Phase 3 |
| Not Yet Recruiting | BCC-One-Stop-Study NCT07482956 | University Hospital Augsburg | N/A |
| Recruiting | Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Mar NCT07182240 | Roswell Park Cancer Institute | N/A |
| Recruiting | The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and NCT07285044 | Mayo Clinic | Phase 2 |
| Recruiting | Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma NCT06624475 | University of California, San Diego | Phase 2 |
| Recruiting | Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell NCT06600165 | LMU Klinikum | — |
| Recruiting | Raman Spectroscopy and Skin Cancer NCT06384924 | Renee Farrell | — |
| Recruiting | Skin Cancer and Hyperthermia and Radiotherapy NCT06384053 | Kantonsspital Winterthur KSW | N/A |
| Not Yet Recruiting | D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study NCT06273722 | Maastricht University Medical Center | — |
| Recruiting | Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy NCT06473103 | University of Rochester | N/A |
| Recruiting | Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical NCT06448936 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Active Not Recruiting | Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) NCT06422936 | Highlight Therapeutics | Phase 2 |
| Completed | CivaDerm(TM) Surface Therapy Pilot Study NCT04480645 | CivaTech Oncology | EARLY_Phase 1 |
| Recruiting | Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma NCT06252857 | Maastricht University Medical Center | — |
| Recruiting | To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell C NCT06344052 | Stamford Pharmaceuticals, Inc. | Phase 2 |
| Withdrawn | Optical Coherence Tomography Guided C&D NCT04510727 | University of Miami | N/A |
| Unknown | Remote Assessment of OCT Scans for BCC Detection NCT06273709 | Maastricht University Medical Center | — |
| Active Not Recruiting | Study to Examine Lesions of the Skin Using Confocal Laser Microscopy NCT06598137 | LMU Klinikum | — |
| Unknown | Dermatoscopy Guided Resection for Skin Cancer NCT06342297 | Region Örebro County | N/A |
| Unknown | cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study NCT06024629 | Maastricht University Medical Center | — |
| Active Not Recruiting | Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs NCT06014619 | Maastricht University Medical Center | — |
| Recruiting | Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surg NCT05929664 | Thomas Jefferson University | Phase 2 |
| Recruiting | Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC NCT05741073 | EuMelaReg gGmbH | — |
| Active Not Recruiting | FLASH Radiotherapy for Skin Cancer NCT05724875 | Centre Hospitalier Universitaire Vaudois | N/A |
| Recruiting | Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma NCT05561634 | University Hospital, Lille | Phase 2 |
| Completed | Investigation of Mohs Surgical Margins Using Two Photon Microscopy NCT05814900 | University of Rochester | N/A |
| Unknown | Nevoid Basal Cell Carcinomas in Gorlin Syndrome NCT05898347 | Oslo University Hospital | — |
| Unknown | The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma NCT06150144 | University of Aleppo | Phase 3 |
| Recruiting | A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Unknown | AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma NCT05817279 | Maastricht University Medical Center | — |
| Completed | Mentored Community Gardening for Individuals With Skin Cancer NCT05648604 | University of Arizona | N/A |
| Active Not Recruiting | In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable a NCT04616248 | University of Southern California | Phase 1 |
| Unknown | High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma NCT05698706 | Jacek Calik | N/A |
| Unknown | Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis NCT05247710 | Tampere University Hospital | — |
| Completed | Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysis NCT05634421 | Maastricht University Medical Center | — |
| Completed | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors NCT06046144 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basa NCT05608902 | Centre Hospitalier William Morey - Chalon sur Saône | — |
| Unknown | Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Trea NCT04929535 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 |
| Unknown | New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management NCT05324202 | Dr. Stephanie Geisler | N/A |
| Active Not Recruiting | A Study of Observation and Follow-up in People With Basal Cell Carcinoma NCT05473507 | Memorial Sloan Kettering Cancer Center | — |
| Active Not Recruiting | Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis NCT05202860 | Merete Haedersdal | Phase 2 |
| Unknown | Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms NCT05402046 | MelanomaPRO, Russia | N/A |
| Completed | DERM US and EU Validation Study NCT05126173 | Skin Analytics Limited | — |
| Recruiting | Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in NCT05078047 | UNICANCER | Phase 3 |
| Active Not Recruiting | A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography NCT05294120 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma NCT05188729 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Unknown | Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery NCT05170035 | Bispebjerg Hospital | N/A |
| Unknown | Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Su NCT05234658 | Andalusian Network for Design and Translation of Advanced Therapies | Phase 2 |
| Unknown | Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integra NCT05340543 | Ramsay Générale de Santé | — |
| Recruiting | Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy NCT05020912 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With NCT04916002 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Laser Treatment of Basal Cell Carcinoma NCT04936932 | Sciton | N/A |
| Recruiting | Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registrati NCT05463757 | Maastricht University Medical Center | — |
| Completed | Intratumoral phIL12 GET NCT05077033 | Institute of Oncology Ljubljana | Phase 1 |
| Active Not Recruiting | Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal C NCT04928222 | SkinJect, Inc. | Phase 1 / Phase 2 |
| Recruiting | A Beta-only IL-2 ImmunoTherapY Study NCT05086692 | Medicenna Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma NCT06309836 | Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse | — |
| Completed | Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo NCT04969419 | Momentum Data | — |
| Completed | IFx-Hu2.0 for the Treatment of Patients With Skin Cancer NCT04925713 | TuHURA Biosciences, Inc. | Phase 1 |
| Recruiting | Personalised Immunotherapy Platform NCT06536257 | Melanoma Institute Australia | — |
| Withdrawn | The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to NCT04093401 | University of Wisconsin, Madison | N/A |
| Terminated | RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly NCT05110924 | University Hospital, Ghent | N/A |
| Active Not Recruiting | Anti-PD1-antibody and Pulsed HHI for Advanced BCC NCT04679480 | Reinhard Dummer | Phase 2 |
| Completed | Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment NCT05581342 | Maastricht University Medical Center | N/A |
| Active Not Recruiting | Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma NCT04744935 | Christopher Zachary | N/A |
| Unknown | Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm NCT04695015 | Peking University | — |
| Completed | Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carc NCT04669808 | Sirnaomics | Phase 2 |
| Unknown | SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity NCT04759261 | Trakya University | N/A |
| Terminated | Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer NCT04410874 | Ivan Litvinov | Phase 1 / Phase 2 |
| Completed | Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma NCT04552990 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor NCT04416516 | Ascend Biopharmaceuticals Ltd | Phase 2 |
| Enrolling By Invitation | HRQoL Keratinocyte Carcinomas NCT04814953 | University Hospital, Ghent | — |
| Unknown | Skin Tumor Biomarkers by Mass Spectrometry Imaging NCT06227416 | Bispebjerg Hospital | N/A |
| Terminated | Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containi NCT03646188 | SkinJect, Inc. | Phase 1 |
| Recruiting | Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin NCT04349436 | Replimune, Inc. | Phase 1 / Phase 2 |
| Completed | Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation NCT04795297 | University Hospital, Montpellier | — |
| Unknown | Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study NCT05046262 | Bispebjerg Hospital | Phase 3 |
| Completed | BCC Excision Revisited NCT05853315 | Medical University of Vienna | — |
| Withdrawn | A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer NCT04099446 | ProgenaBiome | — |
| Completed | Fast Track Diagnosis of Skin Cancer by Advanced Imaging NCT04229277 | University Hospital Bispebjerg and Frederiksberg | N/A |
| Unknown | A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessibl NCT03982212 | University of Kansas Medical Center | Phase 1 |
| Completed | A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Car NCT03534947 | Melanoma Institute Australia | Phase 2 |
| Terminated | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage NCT04688749 | Aristotle University Of Thessaloniki | — |
| Completed | CemiplimAb Survivorship Epidemiology NCT03836105 | Regeneron Pharmaceuticals | — |
| Completed | Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma NCT03889912 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Ca NCT04066504 | Sun Pharmaceutical Industries Limited | — |
| Unknown | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metas NCT03775525 | Genzada Pharmaceuticals USA, Inc. | Phase 1 |
| Unknown | (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) NCT03848078 | Maastricht University Medical Center | N/A |
| Unknown | A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors NCT03734913 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic NCT03521830 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma NCT03714529 | Herlev and Gentofte Hospital | Phase 2 |
| Unknown | Study Assessing the Safety and Performance of Smart Matrix® NCT03742726 | Smart Matrix Limited | N/A |
| Completed | Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma NCT03467789 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors NCT03517488 | Xencor, Inc. | Phase 1 |
| Completed | T-VEC in Non-melanoma Skin Cancer NCT03458117 | University of Zurich | Phase 1 |
| Completed | Topical Vitamin C for Treatment of Basal Cell Cancer NCT04279535 | Center for Biomedical Research, Inc. | EARLY_Phase 1 |
| Unknown | Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin. NCT03972748 | Hospital de Clinicas de Porto Alegre | N/A |
| Terminated | How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes NCT03370861 | Washington University School of Medicine | — |
| Completed | Photographing the Skin During Photodynamic Therapy NCT03167762 | University of Dundee | N/A |
| Completed | Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery NCT03610620 | Julie Dawson | N/A |
| Unknown | Molecular Characterization of Cutaneous Tumors NCT03092830 | Rabin Medical Center | — |
| Completed | Reflectance Confocal Microscopy to Diagnose BCC NCT03509415 | Skin Care Network Ltd. | — |
| Completed | RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma NCT03331874 | Julie Dawson | — |
| Unknown | Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma NCT05041777 | Maastricht University Medical Center | — |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma NCT03035188 | SRH Wald-Klinikum Gera GmbH | Phase 2 |
| Completed | Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo NCT02902822 | Centro Studi Gised | N/A |
| Completed | Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions NCT02781389 | University Hospital, Essen | — |
| Completed | Strategies to Promote Skin Health NCT03237013 | San Diego State University | N/A |
| Completed | Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas NCT02639117 | University of Arizona | Phase 1 |
| Unknown | The Role of Melanocyte in Basal Cell Carcinoma NCT02576769 | Universidad Autonoma de San Luis Potosí | — |
| Completed | Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma NCT02662244 | University of California, San Diego | N/A |
| Completed | Using MC1R Genotype to Impact Melanoma Risk Behavior NCT03509467 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Completed | Utility of the Skin Cancer Quality of Life Impact Tool NCT02580916 | Oxford University Hospitals NHS Trust | N/A |
| Completed | Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina NCT02438644 | Hoffmann-La Roche | — |
| Completed | EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds NCT02409628 | Neotherix Limited | N/A |
| Completed | A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal C NCT02371967 | Hoffmann-La Roche | — |
| Completed | Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma NCT02825511 | University Hospital, Bordeaux | — |
| Unknown | Skin Cancer Screening Education Study NCT02352428 | Association of Dermatological Prevention, Germany | N/A |
| Withdrawn | Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery NCT02321982 | Dartmouth-Hitchcock Medical Center | N/A |
| Completed | An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell NCT02296970 | University of Pittsburgh | — |
| Completed | Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) NCT02667574 | University Hospital, Lille | Phase 2 |
| Terminated | Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold NCT02059252 | Smart Matrix Limited | Phase 1 / Phase 2 |
| Completed | Video-Based Treatment Options for Basal Cell Carcinoma NCT02158650 | Emory University | N/A |
| Completed | Topical Itraconazole in the Treatment of Basal Cell Carcinoma NCT02120677 | Johns Hopkins University | EARLY_Phase 1 |
| Terminated | A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma NCT01898598 | Hoffmann-La Roche | Phase 2 |
| Completed | Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm f NCT01872130 | Memorial Sloan Kettering Cancer Center | — |
| Completed | A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas NCT01815840 | Hoffmann-La Roche | Phase 2 |
| Completed | Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes NCT01700049 | Mayo Clinic | Phase 2 |
| Completed | Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas NCT02125669 | Hautklinik Darmstadt | N/A |
| Terminated | An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carc NCT01604252 | Genentech, Inc. | — |
| Completed | Vismodegib for Treatment of Basal Cell Carcinoma NCT01543581 | Abel Torres, MD | Phase 2 |
| Completed | IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 NCT01609179 | Infinity Pharmaceuticals, Inc. | N/A |
| Completed | Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Hist NCT01540695 | Abramson Cancer Center at Penn Medicine | — |
| Completed | Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors NCT01529450 | Anne Chang | N/A |
| Completed | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? NCT01770002 | University of California, Davis | N/A |
| Unknown | Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell C NCT01903239 | Thomas Jefferson University | N/A |
| Completed | Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma NCT01358045 | Maastricht University Medical Center | Phase 2 |
| Completed | Microarray Analysis of microRNA Expression in Basal Cell Carcinoma NCT01498250 | Ruhr University of Bochum | — |
| Completed | Set-back Suture Versus Traditional Vertical Mattress Suture NCT01773447 | University of California, Davis | N/A |
| Completed | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma NCT01367665 | Hoffmann-La Roche | Phase 2 |
| Completed | A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma NCT01327053 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Clinical Diagnosis of Basal Cell Carcinoma Subtype NCT01370824 | Maastricht University Medical Center | — |
| Completed | Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma NCT01350115 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery NCT01298167 | Yale University | N/A |
| Unknown | Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malig NCT01265472 | Rambam Health Care Campus | — |
| Completed | An East Asian Study of LDE225 NCT01208831 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Fractional CO2 Laser Assisted Photodynamic Therapy NCT01260987 | Bispebjerg Hospital | Phase 2 / Phase 3 |
| Completed | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma NCT01201915 | Genentech, Inc. | Phase 2 |
| Completed | Pilot Study of PDL to Treat BCC and SCCIS NCT01245972 | University of California, San Diego | N/A |
| Approved For Marketing | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma NCT01160250 | Genentech, Inc. | — |
| Completed | A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions NCT01014819 | UCSF Benioff Children's Hospital Oakland | — |
| Completed | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I NCT00959647 | Genentech, Inc. | Phase 2 |
| Completed | Electronic Brachytherapy for the Treatment of NMSC NCT01016899 | Xoft, Inc. | — |
| Completed | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors NCT00880308 | Novartis Pharmaceuticals | Phase 1 |
| Completed | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients Wi NCT00833417 | Genentech, Inc. | Phase 2 |
| Completed | Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma NCT01212549 | University of Ioannina | Phase 3 |
| Completed | Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer NCT00836342 | Massachusetts General Hospital | — |
| Unknown | Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control NCT00663650 | Queen's University | Phase 3 |
| Completed | The Impact of Total Body Skin Examination on Skin Cancer Detection NCT00765193 | Medical University of Graz | N/A |
| Completed | Basal Cell Carcinoma Recurrence After Mohs Surgery NCT00882791 | Northwestern University | — |
| Completed | Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma NCT01015898 | Shahid Beheshti University of Medical Sciences | Phase 1 |
| Completed | Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions NCT01403480 | Rambam Health Care Campus | — |
| Completed | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma NCT00985829 | Shahid Beheshti University of Medical Sciences | Phase 1 |
| Completed | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up NCT00988455 | Shahid Beheshti University of Medical Sciences | Phase 1 / Phase 2 |
| Completed | Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) NCT00581425 | The University of Texas Health Science Center, Houston | Phase 4 |
| Completed | Effect of the Subconscious on Mohs Micrographic Surgery NCT00374062 | Northwestern University | N/A |
| Completed | Photochemical Tissue Bonding NCT00586040 | Massachusetts General Hospital | Phase 2 |
| Completed | Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery NCT00793169 | Northwestern University | — |
| Completed | Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery NCT01212562 | University of Ioannina | — |
| Completed | Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographi NCT00578214 | Mayo Clinic | N/A |
| Completed | Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the S NCT00574392 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. NCT00601185 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors NCT00449358 | Assuta Hospital Systems | N/A |
| Completed | Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage NCT00314756 | Wake Forest University | Phase 4 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma NCT00108121 | Peplin | Phase 2 |
| Completed | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma NCT00108134 | Peplin | Phase 2 |
| Completed | An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants NCT02100111 | Hoffmann-La Roche | — |
| Completed | A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence NCT00129519 | Graceway Pharmaceuticals, LLC | Phase 3 |
| Completed | Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-me NCT00472459 | Galderma R&D | Phase 3 |
| Completed | Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum NCT00046189 | National Cancer Institute (NCI) | — |
| Completed | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma NCT00189241 | MEDA Pharma GmbH & Co. KG | Phase 3 |
| Completed | Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Prima NCT00472108 | Galderma R&D | Phase 3 |
| Completed | PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call C NCT00472043 | Galderma R&D | Phase 3 |
| Completed | Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma NCT00473343 | Galderma R&D | Phase 3 |
| Completed | Optical Biopsy of Human Skin in Conjunction With Laser Treatment NCT00540566 | University of California, Irvine | — |
| Completed | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multipl NCT00005660 | National Cancer Institute (NCI) | — |
| Unknown | Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma NCT01603810 | Maidstone & Tunbridge Wells NHS Trust | — |
| Withdrawn | Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Pati NCT03070691 | Novartis Pharmaceuticals | Phase 2 / Phase 3 |
| Terminated | Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of t NCT00049959 | QLT Inc. | Phase 3 |
| Unknown | A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage a NCT00463359 | University of Glasgow | N/A |
| No Longer Available | Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actini NCT00535080 | Galderma R&D | — |